12:00 AM
 | 
May 21, 2012
 |  BC Week In Review  |  Company News  |  Deals

Oval Medical deal

An undisclosed pharma and Oval partnered to evaluate combining the pharma's drug with Oval's...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >